Elísabeth Pérez-Ruiz

3.2k total citations · 1 hit paper
80 papers, 1.9k citations indexed

About

Elísabeth Pérez-Ruiz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Elísabeth Pérez-Ruiz has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Elísabeth Pérez-Ruiz's work include Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Elísabeth Pérez-Ruiz is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Elísabeth Pérez-Ruiz collaborates with scholars based in Spain, Sweden and United States. Elísabeth Pérez-Ruiz's co-authors include Ignacio Melero, Marilina García‐Aranda, Maximino Redondo, Joanna Kopecka, Javier De Las Rivas, Ana Bela Sarmento‐Ribeiro, Pedro Berraondo, Luna Minute, María C. Ochoa and Emilio Alba and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elísabeth Pérez-Ruiz

76 papers receiving 1.9k citations

Hit Papers

Prophylactic TNF blockade uncouples efficacy and toxicity... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
    2019 323 citations Elísabeth Pérez-Ruiz, Luna Minute et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elísabeth Pérez-Ruiz Spain 20 1.0k 600 574 339 302 80 1.9k
Qingzhu Jia China 21 971 0.9× 627 1.0× 628 1.1× 551 1.6× 418 1.4× 55 2.4k
Steffen Ormanns Germany 20 1.0k 1.0× 428 0.7× 486 0.8× 315 0.9× 434 1.4× 70 1.6k
Saman Maleki Vareki Canada 22 1.3k 1.2× 624 1.0× 665 1.2× 418 1.2× 251 0.8× 53 2.1k
Sandrine Aspeslagh Belgium 26 1.4k 1.4× 843 1.4× 661 1.2× 345 1.0× 218 0.7× 89 2.5k
Jermaine Coward Australia 23 1.2k 1.2× 404 0.7× 704 1.2× 380 1.1× 354 1.2× 87 2.3k
Afshin Derakhshani Iran 26 812 0.8× 655 1.1× 764 1.3× 223 0.7× 424 1.4× 70 2.0k
Yubin Kang United States 24 614 0.6× 459 0.8× 748 1.3× 269 0.8× 162 0.5× 97 1.9k
Inês Pires da Silva Australia 25 1.0k 1.0× 808 1.3× 539 0.9× 247 0.7× 196 0.6× 106 2.0k
William W. Tseng United States 25 912 0.9× 364 0.6× 604 1.1× 815 2.4× 286 0.9× 67 2.0k

Countries citing papers authored by Elísabeth Pérez-Ruiz

Since Specialization
Citations

This map shows the geographic impact of Elísabeth Pérez-Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elísabeth Pérez-Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elísabeth Pérez-Ruiz more than expected).

Fields of papers citing papers by Elísabeth Pérez-Ruiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elísabeth Pérez-Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elísabeth Pérez-Ruiz. The network helps show where Elísabeth Pérez-Ruiz may publish in the future.

Co-authorship network of co-authors of Elísabeth Pérez-Ruiz

This figure shows the co-authorship network connecting the top 25 collaborators of Elísabeth Pérez-Ruiz. A scholar is included among the top collaborators of Elísabeth Pérez-Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elísabeth Pérez-Ruiz. Elísabeth Pérez-Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Berciano‐Guerrero, Miguel‐Ángel, Rocío Lavado-Valenzuela, Édouard Auclin, et al.. (2025). Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanoma. Scientific Reports. 15(1). 25430–25430. 1 indexed citations
3.
Oliver, Javier, Manuel Cobo, José Carlos Benítez, et al.. (2023). Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade. Cancers. 15(13). 3357–3357. 3 indexed citations
4.
Oliver, Javier, Arthur Eumann Mesas, Antonio Rueda‐Domínguez, et al.. (2023). Dynamic Exosome Analysis to Predict Response to the Combination of SABR and Immunotherapy in Oligoprogressive Disease. International Journal of Radiation Oncology*Biology*Physics. 117(2). e274–e275. 1 indexed citations
5.
Guenette, Jeffrey P., Nicole G. Chau, Cyrus Sayehli, et al.. (2020). Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer. Cancer. 126(17). 3972–3981. 37 indexed citations
6.
Fernández-Mateos, Javier, Miguel Pastor Borgoñón, Elísabeth Pérez-Ruiz, et al.. (2019). Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population. Cancers. 11(4). 493–493. 17 indexed citations
7.
García‐Aranda, Marilina, Elísabeth Pérez-Ruiz, & Maximino Redondo. (2018). Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy. International Journal of Molecular Sciences. 19(12). 3950–3950. 117 indexed citations
8.
Ochoa, María C., Luna Minute, Elísabeth Pérez-Ruiz, et al.. (2017). Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15. OncoImmunology. 7(2). e1393597–e1393597. 22 indexed citations
9.
Pérez-Ruiz, Elísabeth, Antonio Rueda, Francisco Rivas‐Ruiz, et al.. (2017). Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer. Pathology & Oncology Research. 24(4). 871–879. 3 indexed citations
10.
Blancas, Isabel, M. Fontanillas, J. Lao, et al.. (2017). Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice. Clinical & Translational Oncology. 20(7). 862–869. 4 indexed citations
11.
12.
Girón, Rosa, María Dolores Pastor‐Vivero, C. Prados, et al.. (2016). 125 Influence of pulmonary exacerbations on health status of cystic fibrosis patients. Health UTIlities and Quality of Life Study (HUTIQOL). Journal of Cystic Fibrosis. 15. S82–S83. 1 indexed citations
13.
Pérez-Ruiz, Elísabeth, Gokul M. Das, Andreas Bergmann, & Eric H. Baehrecke. (2014). Autophagy regulates tissue overgrowth in a context-dependent manner. Oncogene. 34(26). 3369–3376. 32 indexed citations
14.
Pérez-Ruiz, Elísabeth, et al.. (2013). Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature. Journal of Medical Case Reports. 7(1). 127–127. 12 indexed citations
15.
Pérez-Ruiz, Elísabeth, Maximino Redondo, Martina Álvarez, et al.. (2012). Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation. Clinical & Translational Oncology. 14(9). 682–688. 7 indexed citations
16.
Sánchez‐Muñoz, Alfonso, Elísabeth Pérez-Ruiz, Nuria Ribelles, et al.. (2010). Outcome of Small Invasive Breast Cancer with No Axillary Lymph Node Involvement. The Breast Journal. 17(1). 32–38. 8 indexed citations
17.
Sánchez‐Muñoz, Alfonso, et al.. (2010). Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy. American Journal of Clinical Oncology. 34(4). 395–400. 17 indexed citations
18.
Sánchez‐Muñoz, Alfonso, Elísabeth Pérez-Ruiz, Begoña Jiménez, et al.. (2009). Targeted therapy of metastatic breast cancer. Clinical & Translational Oncology. 11(10). 643–650. 28 indexed citations
19.
Klass, Oliver, Uwe Fischer, Elísabeth Pérez-Ruiz, et al.. (2004). Effect of the Na+/H+ exchange inhibitor eniporide on cardiac performance and myocardial high energy phosphates in pigs subjected to cardioplegic arrest. The Annals of Thoracic Surgery. 77(2). 658–663. 9 indexed citations
20.
Pérez-Ruiz, Elísabeth, et al.. (2002). [Mental disorders in patients with spinocerebellar ataxia type 2 in Cuba].. PubMed. 35(9). 818–21. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingzhu Jia Breakdown of academic impact, for papers by Steffen Ormanns Breakdown of academic impact, for papers by Saman Maleki Vareki Breakdown of academic impact, for papers by Sandrine Aspeslagh Breakdown of academic impact, for papers by Jermaine Coward Breakdown of academic impact, for papers by Afshin Derakhshani Breakdown of academic impact, for papers by Yubin Kang Breakdown of academic impact, for papers by Inês Pires da Silva Breakdown of academic impact, for papers by William W. Tseng
Rankless by CCL
2026